Download PDF version
At Teva we believe that every one of us should have access to quality medicine that helps manage disease, fight infection, or simply improves overall health. That is why a substantial part of our business today and a significant portion of our research and development budget is focused on generic medicines.
Around 200 million people worldwide take one of our medicines every day. In the United States, where Teva is the leading generic pharmaceutical company, one out of every nine prescriptions is filled by a Teva product. In the UK it is one out of every six and in Canada it is one out of every six. In addition, many prescription medications made by other companies include active pharmaceutical ingredients produced by Teva.
With generic products, patients usually pay less while receiving the equivalent medicine to what is in the reference brand drug product. Generic medicines cost, on average, 80–85% less than the reference brand drug products. They account for 90% of prescription medicine in the United States and 78% in Germany today. But they only make up 22% of total spending on prescription medicine in the United States and 30% in Germany.
Teva’s generic products support healthcare systems. Patients and healthcare providers in the United States saved more than $259 billion in the last decade by choosing Teva’s prescription generic medicine over more expensive brands.
Our global footprint is critical to ensuring that patients have access to our medicines. Teva has the largest supply chain of any pharmaceutical company and our network of about 40,000 employees and close to 60 global manufacturing sites work around the clock to make sure our medicines reach patients in over 60 countries across six continents. Every hour there is a plane in the air, a ship on the seas or a truck on the road delivering Teva’s generic medicines to pharmacies and hospitals around the world.
We are committed to creating quality, affordable medicines for more people in more places around the world. Our scientists are currently developing over 800 generic medicines that aim to increase access to treatments that can improve patients’ health and save healthcare providers billions. Teva continues to strive for a healthier world.
Find out more
- Read our Generics FAQs
- Discover how we support almost 200 million patients every day with quality products that improve lives
- Our speciality areas include treatments for respiratory, pain, migraine and oncology – find out more
- Would you like to be part of the work we are doing at Teva? Visit our careers page